Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMP7 and Bone Marrow for Femoral Head Necrosis
NCT02655120Terminated
- Sponsor
- CHU de Lille
- Start
- Mar 2005
- Primary completion
- May 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised, double-blind trial of bone morphogenetic protein 7 in osteonecrosis of the femoral head (ONFH) (2 arms), sponsored by CHU de Lille. Primary endpoint: Necrosis volume assessed by MRI at 24 months. Started Mar 2005; status: terminated.
02
Drugs
bone morphogenetic protein 7
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT02655120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655120.